0001181431-13-015377.txt : 20130307
0001181431-13-015377.hdr.sgml : 20130307
20130307164744
ACCESSION NUMBER: 0001181431-13-015377
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130305
FILED AS OF DATE: 20130307
DATE AS OF CHANGE: 20130307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FERRARI LOUIS
CENTRAL INDEX KEY: 0001513697
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15313
FILM NUMBER: 13673975
MAIL ADDRESS:
STREET 1: 765 WARREN STREET
CITY: WARRREN STREET
STATE: NJ
ZIP: 07090
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000722104
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 133033811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
BUSINESS PHONE: 7324189300
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
FORMER COMPANY:
FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP
DATE OF NAME CHANGE: 19920703
4
1
rrd373150.xml
FERRARI FORM 4
X0306
4
2013-03-05
0
0000722104
SAVIENT PHARMACEUTICALS INC
SVNT
0001513697
FERRARI LOUIS
SAVIENT PHARMACEUTICALS, INC.
400 CROSSING BLVD.
BRIDGEWATER
NJ
08807
1
1
0
0
President and CEO
Common Stock
308459
D
Option to Purchase Common Stock
0.94
2013-03-05
4
A
0
180000
0
A
2023-03-05
Common Stock
180000
180000
D
Option to Purchase Common Stock
2.26
2013-03-05
4
A
0
60200
0
A
2022-02-01
Common Stock
60200
60200
D
Option to Purchase Common Stock
0.56
2012-07-09
4
A
0
150000
0
A
2022-07-09
Common Stock
150000
150000
D
These options will vest in proportional 25% increments on each of the first four anniversaries of the grant date, March 5, 2013.
These options reflect the vesting of performance options that were granted to the reporting person effective February 1, 2012.
These performance options were granted effective July 9, 2012 and vest, if at all, in proportional 25% increments if the closing price of Savient's common stock during any period of 30 consecutive calendar days equals or exceeds certain pre-agreed share prices.
Philip K. Yachmetz as attorney-in-fact for Louis Ferrari
2013-03-07